First Horizon Advisors Inc. Sells 2,035 Shares of Colgate-Palmolive Company $CL

First Horizon Advisors Inc. lowered its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 12.0% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 14,866 shares of the company’s stock after selling 2,035 shares during the period. First Horizon Advisors Inc.’s holdings in Colgate-Palmolive were worth $1,351,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in CL. Brighton Jones LLC grew its holdings in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares in the last quarter. Penserra Capital Management LLC boosted its stake in Colgate-Palmolive by 398.6% during the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock worth $997,000 after buying an additional 8,515 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in Colgate-Palmolive by 24.6% in the 1st quarter. Envestnet Asset Management Inc. now owns 675,584 shares of the company’s stock valued at $63,302,000 after buying an additional 133,327 shares during the period. U.S. Capital Wealth Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at $205,000. Finally, Personal CFO Solutions LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter worth about $285,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $77.25 on Friday. The business’s fifty day moving average is $79.84 and its two-hundred day moving average is $85.88. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a market cap of $62.44 billion, a P/E ratio of 21.70, a P/E/G ratio of 4.44 and a beta of 0.35. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.91 earnings per share. Equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is 58.26%.

Analyst Ratings Changes

Several research analysts recently issued reports on CL shares. Barclays dropped their price target on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research report on Tuesday. The Goldman Sachs Group cut their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft set a $86.00 price target on Colgate-Palmolive in a research report on Friday, October 10th. Raymond James Financial cut their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, October 20th. Finally, UBS Group lowered their target price on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a report on Monday. Nine analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $89.87.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.